The application of phosphoramidate ProTide technology to acyclovir confers anti-HIV inhibition - Bertin Instruments
The application of phosphoramidate ProTide technology to acyclovir confers anti-HIV inhibition
Marco Derudas+, Davide Carta+, Andrea Brancale+, Christophe Vanpouille++, Andrea Lisco++, Leonid Margolis++, Jan Balzarini+++, and Christopher McGuigan+,*
Sources: +Welsh School of Pharmacy, Cardiff University, Cardiff, CF10 3NB, UK++Eunice Kennedy Shriver National Institute of Child Health and Human Development, NationalInstitutes of Health, Bethesda, MD 20892, USA+++Rega Institute for Medical Research, Katholieke Universiteit, Leuven, B-3000, Belgium
J Med Chem. 2009 September 10; 52(17): 5520-5530. doi:10.1021/jm9007856.